SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPulsar Group Regulatory News (PULS)

Share Price Information for Pulsar Group (PULS)

Share Price is delayed by 15 minutes
Get Live Data
38.50    0.00 (0.00%)
Bid:
37.00
Ask:
40.00
Spread: 3.00 (8.108%)
Market Cap: £52.20m
PULS Live PriceLast checked at - London Stock Exchange

Intraday Pulsar Group Share Chart

Director/PDMR Shareholding

10 Apr 2026 11:35

RNS Number : 0268A
Pulsar Group PLC
10 April 2026
 

10 April 2026

 

Pulsar Group plc

("Pulsar" or the "Company")

Director/PDMR Shareholdings

Pulsar Group plc (AIM: PULS) announces that it has received notification from Mr. Max Royde, Non-Executive Director of the Company, that an aggregate of 31,500 ordinary shares of 5 pence each in the Company ("Ordinary Shares") have been transferred out of Kestrel Partners LLP's ("Kestrel") discretionary management and control due to the rearrangement of one client portfolio. These Ordinary Shares continue to be held by the same beneficial owner.

Mr. Royde is a partner of, and holds a beneficial interest in, Kestrel. Mr. Royde is also a shareholder in the Kestrel Opportunities Fund ("Kestrel Opportunities") and is therefore deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding of Ordinary Shares in the Company.

Following this transaction, Kestrel Opportunities continues to hold (and consequently Mr. Royde is deemed to have a beneficial interest in) 20,227,082 Ordinary Shares, and other discretionary management clients of Kestrel, in which Mr. Royde has no beneficial interest hold 18,450,160 Shares in the Company.

On a combined basis, Kestrel indirectly holds voting rights over 38,677,242 Ordinary Shares in the Company, which represents approximately 28.52% of the total voting rights in the Company.

Kestrel's interest in the Ordinary Shares in the Company is held through the following nominees:

Nominee

No. of Ordinary Shares

% of total voting rights

Bank of New York Nominees Ltd

20,227,082

14.92%

Bank of New York Nominees Ltd

10,576,173

7.80%

Northern Trust Company AVFC

6,097,181

4.49%

iDealing Nominees Limited

1,010,887

0.75%

CB NYK - CITIBANK N.A.-PRIVATE BK

333,333

0.24%

An individual Client at Fidelity International Limited

416,666

0.31%

An individual in certificated form

15,920

0.01%

 

For further information contact:

Pulsar Group plc

Joanna Arnold (CEO)

Mark Fautley (CFO)

 020 3426 4070

 

 

Cavendish Capital Markets Limited (Nominated Adviser and Broker)

Corporate Finance:

Marc Malmo / Fergus Sullivan / Elysia Bough

 

Corporate Broking

Sunila de Silva

020 7220 0500 

 

 

 

ANNEX

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Max Royde

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PCA - Kestrel Partners LLP are a PCA of Max Royde (Non-Executive Director of the Company) and Partner of Kestrel).

b)

 

Initial notification /Amendment

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Pulsar Group plc

b)

 

LEI

 

213800PPZ4ZM8OMHGT41

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Identification code

 

Ordinary Shares of 5 pence each

 

 

ISIN: GB00BGQVB052

 

b)

 

Nature of the transaction

 

Transfer of Ordinary Shares out of Kestrel controlled accounts. Mr. Royde is a partner of, and holds a beneficial interest in, Kestrel. Mr. Royde is also a shareholder in one of Kestrel's clients ("Kestrel Opportunities") and is therefore deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding in Shares in the Company.

c)

 

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

N/A

31,500

d)

 

Aggregated information

- Aggregated volume

- Price

 

As above.

 

e)

 

Date of the transaction

07 April 2026

f)

 

Place of the transaction

N/A

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHAKKBBKBKDAQD
Date   Source Headline
28th May 20263:30 pmRNSResult of Annual General Meeting
7th May 202612:50 pmRNSPosting of Annual Report and Notice of AGM
1st May 20267:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 30 NOVEMBER 2025
10th Apr 202611:35 amRNSDirector/PDMR Shareholding
7th Apr 20266:10 pmRNSDirector/PDMR Shareholding
27th Feb 20262:13 pmRNSDirectors' Dealings
24th Feb 20265:21 pmRNSHolding(s) in Company
20th Feb 20267:00 amRNSTrading Update
16th Jan 20267:00 amRNSHolding(s) in Company
16th Jan 20267:00 amRNSHolding(s) in Company
15th Jan 20264:32 pmRNSHolding(s) in Company
14th Jan 20264:44 pmRNSHolding(s) in Company
23rd Dec 20257:00 amRNSMajor Global Contract Win
23rd Dec 20257:00 amRNSMajor Global Contract Win
15th Dec 20254:05 pmRNSDirector/PDMR Shareholding
26th Sep 20255:42 pmRNSHolding(s) in Company
9th Sep 20256:23 pmRNSHolding(s) in Company
8th Sep 20257:00 amRNSHolding(s) in Company
14th Jul 20257:00 amRNSInterim Results
18th Jun 202510:25 amRNSHolding(s) in Company
29th May 20253:18 pmRNSResult of Annual General Meeting
14th May 20255:03 pmRNSTR - 1
13th May 202512:17 pmRNSTR-1
13th May 202512:17 pmRNSDirector Dealing
8th May 20257:00 amRNSResult of Placing, Related Parties & TVR
7th May 20254:39 pmRNSProposed Placing
1st May 20257:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 30 NOVEMBER 2024
28th Apr 20257:00 amRNSStrategic Contract Expansion
10th Mar 20255:41 pmRNSHolding(s) in Company
28th Jan 20257:00 amRNSDirectors' Dealings
24th Jan 20257:00 amRNSTrading Update
2nd Dec 20247:00 amRNSDisposal
7th Oct 20249:31 amRNSDirectors’ Dealings
30th Sep 20244:01 pmRNSHolding(s) in Company
30th Sep 20244:00 pmRNSDirectors’ Dealings
16th Sep 202410:06 amRNSChange of Registered Office Address
29th Aug 20247:00 amRNSBoard Changes
1st Aug 20247:00 amRNSBoard Change
15th Jul 20247:00 amRNSEstablishment of Long-Term Incentive Plan
8th Jul 20247:00 amRNSInterim Results
3rd Jul 20244:23 pmRNSResult of General Meeting
13th Jun 202412:10 pmRNSPosting of notice of GM
31st May 20241:23 pmRNSHolding(s) in Company
31st May 202412:45 pmRNSResult of Annual General Meeting
24th May 20247:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 30 NOVEMBER 2023
9th May 20247:00 amRNSPosting of Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.